LibraryScenariosWhen biotech teams struggle to admit a promising compound isn't working
Scenario

When biotech teams struggle to admit a promising compound isn't working

Our biotech startup team has been dancing around the fact that our lead compound isn't performing as expected and we all see it but no one wants to be the person who says we might need to pivot after eighteen months of work. The investors are asking harder questions and we're running out of ways to stay optimistic without being dishonest.

Aurelius
Online
The coach is replying

More people experience this than they realize.

What we've seen

Your team can all see the product isn't working, but nobody wants to be the one to say it after so much effort.

Ideas that help explain it
Worth thinking about

“Where Are You with Healthcare — Biomedical & Clinical Research?”

If this sounds familiar, the Library can help you find the bigger picture.